Information relating to the decided rights issue in Vicore Pharma
The Board of Directors of Vicore Pharma Holding AB (publ) (”Vicore”) informs about the time plan for the rights issue (the ”Rights issue”) that was resolved at the Extraordinary General Meeting on 13 August, 2018.The Rights issue in summary Those registered as shareholders in Vicore on the record date, 17 September 2018, are entitled to receive subscription rights entitling to preferential rights to subscribe for shares in the Rights issue. Each existing share entitles to one (1) subscription right. Three (3) subscription rights entitle to subscription of one (1) share. Insofar as new